en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2020
vol. 95
 
Share:
Send email
Share:
abstract:
Case report

Association of Budd-Chiari syndrome, essential thrombocytosis, and celiac disease

Agnieszka Bakula
1
,
Pawel Laguna
2
,
Joanna Cielecka-Kuszyk
3
,
Andrzej Kosciesza
4
,
Michal Brzewski
5
,
Piotr Socha
1

  1. Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
  2. Department of Paediatrics, Haematology, and Oncology, Medical University of Warsaw, Warsaw, Poland
  3. Deptartment of Pathology, The Children’s Memorial Health Institute, Warsaw, Poland
  4. Deptartment of Radiology, The Children’s Memorial Health Institute, Warsaw, Poland
  5. Deptartment of Radiology, Medical University of Warsaw, Warsaw, Poland
Pediatr Pol 2020; 95 (3): 191–195
DOI: https://doi.org/10.5114/polp.2020.100840
Online publish date: 2020/10/30
View full text Get citation
 
PlumX metrics:
Herein we report the case of a girl with association of Budd-Chiari syndrome (BCS), essential thrombocythaemia (ET), and celiac disease (CD). To our knowledge, this is one out of eight cases in the literature of BCS complicated with CD, and the only one complicated with ET. This case is particularly significant because anagrelide therapy was started at an unusually early age. A four-year-old girl with ET treated with anagrelide was admitted to our hospital with suspicion of BCS. Ultrasound colour Doppler and computed tomography imaging revealed enlargement of the caudate lobe, splenomegaly, accessory hepatic veins, umbilical vein recanalisation, and ascites. The diagnosis of the CD was confirmed by serology (EmA IgA 1 : 800, tTG IgA > 130 U/ml). Two years later Duhring’s disease was confirmed histologically with recovery after diet modification. Four years later she is still being treated with anagrelide, anticoagulant drugs and is on a well-controlled gluten-free diet.
keywords:

children, celiac disease, Budd-Chiari syndrome, essential thrombocythaemia